Koundouros, N
It's worth being honest about the evidence here
Thus far, approximately 40 companies worldwide, including Codiak Biosciences, Evox Therapeutics, Tavec Pharmaceuticals, Carmine Therapeutics, Anjarium, and Micromedmark Biotech, have developed exosome-based therapies, which are expected to provide cost-effective and more accurate targeted therapies in the clinic ( However, challenges, such as large-scale production, purity, and batch homogeneity of exosomes, still limit their clinical application
For instance, STAT3 signaling can induce cellular senescence in many cell types through the STAT3/SOCS/p53 pathway
Nature Chemical Biology 9(5):300-306
Since direct FAQs on this compound solvent issues are unavailable, here is a framework and key considerations you can use to build your guide, drawing from general laboratory practice